Background: Sarcopenia, characterized by a progressive decrease in skeletal muscle
mass and decline in muscle function, is a common factor amongst patients with
chronic kidney disease (CKD). Purpose of review: This narrative review
summarizes the most recent evidence regarding the epidemiology,
pathophysiology, clinical implications, diagnostic criteria, and therapeutic strategies
for sarcopenia in CKD patients. Methods: The study used a recent literature
synthesis method. Results: 25-50% of patients with CKD have the presence of
sarcopenia. Major contributors are chronic inflammation, oxidative stress, and
alterations in hormone signaling. It has been advocated that muscle strength is a
more reliable predictor of poor outcomes than muscle mass. Conclusion: Early
recognition and an organized approach play an important role in enhancing their
clinical course.
Keywords: Sarcopenia, chronic kidney disease, muscle strength, renal
rehabilitation, inflammation